Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.62 USD | -0.22% | +1.71% | +0.51% |
04-18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
04-18 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CERE Stock
- Revisions Cerevel Therapeutics Holdings, Inc.